A case of multisystem inflammatory syndrome (MIS-A) in an adult woman 18 days after COVID-19 vaccination.
Acta Clin Belg
; 77(4): 772-777, 2022 Aug.
Article
en En
| MEDLINE
| ID: mdl-34511054
ABSTRACT
We discuss a case of a young woman, presenting a constellation of clinical and biochemical features meeting the current case definition of multisystem inflammatory syndrome in adults (MIS-A), 18 days after receiving her first dose of the Oxford/AstraZeneca vaccine. Therapy by means of intravenous immunoglobulins was initiated, leading to clinical and biochemical recovery. Although a relationship between MIS-A and the preceding vaccination cannot be confirmed, it can also not be excluded, given the temporal association and the fact that there were no indicators of a preceding SARS-CoV-2 infection.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
2_ODS3
/
4_TD
Problema de salud:
2_enfermedades_transmissibles
/
2_muertes_prematuras_enfermedades_notrasmisibles
/
4_pneumonia
/
4_sepsis
Asunto principal:
Síndrome de Respuesta Inflamatoria Sistémica
/
Vacunas contra la COVID-19
/
COVID-19
Límite:
Adult
/
Female
/
Humans
Idioma:
En
Revista:
Acta Clin Belg
Año:
2022
Tipo del documento:
Article
País de afiliación:
Bélgica